|
|
||||||||
Original Research Communication |
1 From the Departments of Pulmonology, Surgery, and Clinical Chemistry, Maastricht University, Maastricht, Netherlands.
Background: There is increasing evidence of abnormal protein metabolism in patients with chronic obstructive pulmonary disease (COPD), as reflected by lower plasma branched-chain amino acid (BCAA) concentrations and different muscle amino acid (AA) patterns than in age-matched control subjects.
Objective: We examined whether the low plasma BCAA concentrations in COPD reflect an imbalance between anabolic and catabolic processes as evidenced by a low fat-free mass (FFM) and alterations in the anabolic hormone insulin and whether discrepancies in muscle AA concentrations between studies are related to different patient characteristics.
Design: AA profiles in arterial plasma and quadriceps femoris muscle and insulin concentrations in venous plasma were analyzed in 28 postabsorptive COPD patients (14 with and 14 without macroscopic emphysema) and in 28 control subjects. FFM was measured by dual-energy X-ray absorptiometry.
Results: The lower sum of plasma BCAAs in the COPD group than in the control subjects was the result of a lower leucine concentration (P < 0.001); no significant difference in valine and isoleucine was found between the groups. In the COPD group, the lower leucine concentrations were associated with low FFM (P < 0.01). Compared with the control group, the muscle-to-plasma leucine gradient was higher in the COPD group (P < 0.001) and was associated with a higher insulin concentration (P < 0.01). Several muscle AA concentrations were higher or tended to be higher in the group without emphysema than in the control group, whereas nearly all AA concentrations were lower in the group with emphysema.
Conclusions: Leucine metabolism is altered in COPD patients and is associated with low FFM and high insulin concentrations. There were striking differences in the skeletal muscle AA profile between the COPD subtypes.
Key Words: Branched-chain amino acids leucine insulin muscle amino acid profile chronic obstructive pulmonary disease COPD emphysema
This article has been cited by other articles:
![]() |
M. P. Engelen, E. P. Rutten, C. L. De Castro, E. F. Wouters, A. M. Schols, and N. E. Deutz Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, February 1, 2007; 85(2): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S Hopkinson, K. I Eleftheriou, J. Payne, A. H Nickol, E. Hawe, J. Moxham, H. Montgomery, and M. I Polkey +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 912 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Van Winkle, J. K. Tesch, A. Shah, and A. L. Campione System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood Hum. Reprod. Update, March 1, 2006; 12(2): 145 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Rutten, M. P. Engelen, E. F. Wouters, A. M. Schols, and N. E. Deutz Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, January 1, 2006; 83(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Couillard and C. Prefaut From muscle disuse to myopathy in COPD: potential contribution of oxidative stress Eur. Respir. J., October 1, 2005; 26(4): 703 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. A. Rutten, M. P.K.J. Engelen, C. L. N. Castro, E. F. M. Wouters, A. M.W.J. Schols, and N. E. P. Deutz Decreased Whole-Body and Splanchnic Glutamate Metabolism in Healthy Elderly Men and Patients with Chronic Obstructive Pulmonary Disease in the Postabsorptive State and in Response to Feeding J. Nutr., September 1, 2005; 135(9): 2166 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Vissers, C. H. Dejong, Y. C Luiking, K. C. Fearon, M. F von Meyenfeldt, and N. E. Deutz Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1142 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. E. Franssen, R. Broekhuizen, P. P. Janssen, E. F. M. Wouters, and A. M. W. J. Schols Effects of Whole-Body Exercise Training on Body Composition and Functional Capacity in Normal-Weight Patients With COPD Chest, June 1, 2004; 125(6): 2021 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M.W.J. Schols Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Eur. Respir. J., November 2, 2003; 22(46_suppl): 81s - 86s. [Abstract] [Full Text] [PDF] |
||||
![]() |
E F M Wouters Eat well to get well Thorax, September 1, 2003; 58(9): 739 - 740. [Full Text] [PDF] |
||||
![]() |
H.R. Gosker, P. Schrauwen, M.K.C. Hesselink, G. Schaart, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD Eur. Respir. J., July 1, 2003; 22(1): 88 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Engelen, N. E. Deutz, R. Mostert, E. F. Wouters, and A. M. Schols Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema Am. J. Clinical Nutrition, April 1, 2003; 77(4): 868 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
E F M Wouters Chronic obstructive pulmonary disease * 5: Systemic effects of COPD Thorax, December 1, 2002; 57(12): 1067 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ezzell and G. L Jensen Malnutrition in chronic obstructive pulmonary disease Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1415 - 1416. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |